APO RESEARCH · REPORT
3D Bio-Printer
3D Bio-Printer is equipment that deposits specified biological materials in controlled patterns for research or tissue-engineering work.
Product & engineering
Understand the product.
The deposition method, material compatibility, temperature control and research workflow determine the equipment requirement. A printed construct is distinct from clinically validated tissue or a treatment.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which deposition method and biological workflow are supported?
The deposition method, material compatibility, temperature control and research workflow determine the equipment requirement. A printed construct is distinct from clinically validated tissue or a treatment.
Selected research
Industry Research
3D Bio-Printer Industry Research Report 2026
Market perspective
The global 3D Bio-Printer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for 3D Bio-Printer is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for 3D Bio-Printer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for 3D Bio-Printer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of 3D Bio-Printer include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global 3D Bio-Printer market in revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to 3D Bio-Printer.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
3D Bio-Printer Market by Company
3D Biotek, LLC
3Dynamic Systems Ltd
Accellta Ltd
Advanced Solutions, Inc.
Bio3D Technologies
Biobots Inc
Cellink AB
Cyfuse Biomedical K.K
Envision TEC,Inc.
GeSIM
Luxexcel Group BV
Materialise NV
Nano3D Biosciences,Inc.
Organovo Holdings, Inc.
Poietis
RegenHU Ltd.
Regenovo Biotechnology Co,.Ltd
3D Bio-Printer Segment by Type
Magnetic 3D Bio-Printer
Laser-Assisted 3D Bio-Printer
Inkjet 3D Bio-Printer
Microextrusion 3D Bio-Printer
3D Bio-Printer Segment by Application
Medical Devices
Tissue-Engineered Scaffold
Tissue and Organ
3D Bio-Printer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3D Bio-Printer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 3D Bio-Printer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3D Bio-Printer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 3D Bio-Printer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 3D Bio-Printer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 3D Bio-Printer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Magnetic 3D Bio-Printer
- Laser-Assisted 3D Bio-Printer
- Inkjet 3D Bio-Printer
- Microextrusion 3D Bio-Printer
Applications
- Medical Devices
- Tissue-Engineered Scaffold
- Tissue and Organ
Companies covered
- 3D Biotek, LLC
- 3Dynamic Systems Ltd
- Accellta Ltd
- Advanced Solutions, Inc.
- Bio3D Technologies
- Biobots Inc
- Cellink AB
- Cyfuse Biomedical K.K
- Envision TEC,Inc.
- GeSIM
- Luxexcel Group BV
- Materialise NV
- Nano3D Biosciences,Inc.
- Organovo Holdings, Inc.
- Poietis
- RegenHU Ltd.
- Regenovo Biotechnology Co,.Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 3D Bio-Printer by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Magnetic 3D Bio-Printer
- 2.2.3 Laser-Assisted 3D Bio-Printer
- 2.2.4 Inkjet 3D Bio-Printer
- 2.2.5 Microextrusion 3D Bio-Printer
- 2.3 3D Bio-Printer by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medical Devices
- 2.3.3 Tissue-Engineered Scaffold
- 2.3.4 Tissue and Organ
- 2.4 Global Market Growth Prospects
- 2.4.1 Global 3D Bio-Printer Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global 3D Bio-Printer Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global 3D Bio-Printer Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global 3D Bio-Printer Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 3D Bio-Printer Production by Manufacturers (2021-2026)
- 3.2 Global 3D Bio-Printer Production Value by Manufacturers (2021-2026)
- 3.3 Global 3D Bio-Printer Average Price by Manufacturers (2021-2026)
- 3.4 Global 3D Bio-Printer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 3D Bio-Printer Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global 3D Bio-Printer Manufacturers, Product Type & Application
- 3.7 Global 3D Bio-Printer Manufacturers Established Date
- 3.8 Global 3D Bio-Printer Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 3D Biotek, LLC
- 4.1.1 3D Biotek, LLC 3D Bio-Printer Company Information
- 4.1.2 3D Biotek, LLC 3D Bio-Printer Business Overview
- 4.1.3 3D Biotek, LLC 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.1.4 3D Biotek, LLC Product Portfolio
- 4.1.5 3D Biotek, LLC Recent Developments
- 4.2 3Dynamic Systems Ltd
- 4.2.1 3Dynamic Systems Ltd 3D Bio-Printer Company Information
- 4.2.2 3Dynamic Systems Ltd 3D Bio-Printer Business Overview
- 4.2.3 3Dynamic Systems Ltd 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.2.4 3Dynamic Systems Ltd Product Portfolio
- 4.2.5 3Dynamic Systems Ltd Recent Developments
- 4.3 Accellta Ltd
- 4.3.1 Accellta Ltd 3D Bio-Printer Company Information
- 4.3.2 Accellta Ltd 3D Bio-Printer Business Overview
- 4.3.3 Accellta Ltd 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.3.4 Accellta Ltd Product Portfolio
- 4.3.5 Accellta Ltd Recent Developments
- 4.4 Advanced Solutions, Inc.
- 4.4.1 Advanced Solutions, Inc. 3D Bio-Printer Company Information
- 4.4.2 Advanced Solutions, Inc. 3D Bio-Printer Business Overview
- 4.4.3 Advanced Solutions, Inc. 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.4.4 Advanced Solutions, Inc. Product Portfolio
- 4.4.5 Advanced Solutions, Inc. Recent Developments
- 4.5 Bio3D Technologies
- 4.5.1 Bio3D Technologies 3D Bio-Printer Company Information
- 4.5.2 Bio3D Technologies 3D Bio-Printer Business Overview
- 4.5.3 Bio3D Technologies 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.5.4 Bio3D Technologies Product Portfolio
- 4.5.5 Bio3D Technologies Recent Developments
- 4.6 Biobots Inc
- 4.6.1 Biobots Inc 3D Bio-Printer Company Information
- 4.6.2 Biobots Inc 3D Bio-Printer Business Overview
- 4.6.3 Biobots Inc 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.6.4 Biobots Inc Product Portfolio
- 4.6.5 Biobots Inc Recent Developments
- 4.7 Cellink AB
- 4.7.1 Cellink AB 3D Bio-Printer Company Information
- 4.7.2 Cellink AB 3D Bio-Printer Business Overview
- 4.7.3 Cellink AB 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.7.4 Cellink AB Product Portfolio
- 4.7.5 Cellink AB Recent Developments
- 4.8 Cyfuse Biomedical K.K
- 4.8.1 Cyfuse Biomedical K.K 3D Bio-Printer Company Information
- 4.8.2 Cyfuse Biomedical K.K 3D Bio-Printer Business Overview
- 4.8.3 Cyfuse Biomedical K.K 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.8.4 Cyfuse Biomedical K.K Product Portfolio
- 4.8.5 Cyfuse Biomedical K.K Recent Developments
- 4.9 Envision TEC,Inc.
- 4.9.1 Envision TEC,Inc. 3D Bio-Printer Company Information
- 4.9.2 Envision TEC,Inc. 3D Bio-Printer Business Overview
- 4.9.3 Envision TEC,Inc. 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.9.4 Envision TEC,Inc. Product Portfolio
- 4.9.5 Envision TEC,Inc. Recent Developments
- 4.10 GeSIM
- 4.10.1 GeSIM 3D Bio-Printer Company Information
- 4.10.2 GeSIM 3D Bio-Printer Business Overview
- 4.10.3 GeSIM 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.10.4 GeSIM Product Portfolio
- 4.10.5 GeSIM Recent Developments
- 4.11 Luxexcel Group BV
- 4.11.1 Luxexcel Group BV 3D Bio-Printer Company Information
- 4.11.2 Luxexcel Group BV 3D Bio-Printer Business Overview
- 4.11.3 Luxexcel Group BV 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.11.4 Luxexcel Group BV Product Portfolio
- 4.11.5 Luxexcel Group BV Recent Developments
- 4.12 Materialise NV
- 4.12.1 Materialise NV 3D Bio-Printer Company Information
- 4.12.2 Materialise NV 3D Bio-Printer Business Overview
- 4.12.3 Materialise NV 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.12.4 Materialise NV Product Portfolio
- 4.12.5 Materialise NV Recent Developments
- 4.13 Nano3D Biosciences,Inc.
- 4.13.1 Nano3D Biosciences,Inc. 3D Bio-Printer Company Information
- 4.13.2 Nano3D Biosciences,Inc. 3D Bio-Printer Business Overview
- 4.13.3 Nano3D Biosciences,Inc. 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.13.4 Nano3D Biosciences,Inc. Product Portfolio
- 4.13.5 Nano3D Biosciences,Inc. Recent Developments
- 4.14 Organovo Holdings, Inc.
- 4.14.1 Organovo Holdings, Inc. 3D Bio-Printer Company Information
- 4.14.2 Organovo Holdings, Inc. 3D Bio-Printer Business Overview
- 4.14.3 Organovo Holdings, Inc. 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.14.4 Organovo Holdings, Inc. Product Portfolio
- 4.14.5 Organovo Holdings, Inc. Recent Developments
- 4.15 Poietis
- 4.15.1 Poietis 3D Bio-Printer Company Information
- 4.15.2 Poietis 3D Bio-Printer Business Overview
- 4.15.3 Poietis 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.15.4 Poietis Product Portfolio
- 4.15.5 Poietis Recent Developments
- 4.16 RegenHU Ltd.
- 4.16.1 RegenHU Ltd. 3D Bio-Printer Company Information
- 4.16.2 RegenHU Ltd. 3D Bio-Printer Business Overview
- 4.16.3 RegenHU Ltd. 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.16.4 RegenHU Ltd. Product Portfolio
- 4.16.5 RegenHU Ltd. Recent Developments
- 4.17 Regenovo Biotechnology Co,.Ltd
- 4.17.1 Regenovo Biotechnology Co,.Ltd 3D Bio-Printer Company Information
- 4.17.2 Regenovo Biotechnology Co,.Ltd 3D Bio-Printer Business Overview
- 4.17.3 Regenovo Biotechnology Co,.Ltd 3D Bio-Printer Production, Value and Gross Margin (2021-2026)
- 4.17.4 Regenovo Biotechnology Co,.Ltd Product Portfolio
- 4.17.5 Regenovo Biotechnology Co,.Ltd Recent Developments
5 Global 3D Bio-Printer Production by Region
- 5.1 Global 3D Bio-Printer Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global 3D Bio-Printer Production by Region: 2021-2032
- 5.2.1 Global 3D Bio-Printer Production by Region: 2021-2026
- 5.2.2 Global 3D Bio-Printer Production Forecast by Region (2027-2032)
- 5.3 Global 3D Bio-Printer Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global 3D Bio-Printer Production Value by Region: 2021-2032
- 5.4.1 Global 3D Bio-Printer Production Value by Region: 2021-2026
- 5.4.2 Global 3D Bio-Printer Production Value Forecast by Region (2027-2032)
- 5.5 Global 3D Bio-Printer Market Price Analysis by Region (2021-2026)
- 5.6 Global 3D Bio-Printer Production and Value, YOY Growth
- 5.6.1 North America 3D Bio-Printer Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe 3D Bio-Printer Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China 3D Bio-Printer Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan 3D Bio-Printer Production Value Estimates and Forecasts (2021-2032)
6 Global 3D Bio-Printer Consumption by Region
- 6.1 Global 3D Bio-Printer Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global 3D Bio-Printer Consumption by Region (2021-2032)
- 6.2.1 Global 3D Bio-Printer Consumption by Region: 2021-2026
- 6.2.2 Global 3D Bio-Printer Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 3D Bio-Printer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 3D Bio-Printer Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 3D Bio-Printer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 3D Bio-Printer Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 3D Bio-Printer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 3D Bio-Printer Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa 3D Bio-Printer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa 3D Bio-Printer Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global 3D Bio-Printer Production by Type (2021-2032)
- 7.1.1 Global 3D Bio-Printer Production by Type (2021-2032) & (k units)
- 7.1.2 Global 3D Bio-Printer Production Market Share by Type (2021-2032)
- 7.2 Global 3D Bio-Printer Production Value by Type (2021-2032)
- 7.2.1 Global 3D Bio-Printer Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global 3D Bio-Printer Production Value Market Share by Type (2021-2032)
- 7.3 Global 3D Bio-Printer Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global 3D Bio-Printer Production by Application (2021-2032)
- 8.1.1 Global 3D Bio-Printer Production by Application (2021-2032) & (k units)
- 8.1.2 Global 3D Bio-Printer Production Market Share by Application (2021-2032)
- 8.2 Global 3D Bio-Printer Production Value by Application (2021-2032)
- 8.2.1 Global 3D Bio-Printer Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global 3D Bio-Printer Production Value Market Share by Application (2021-2032)
- 8.3 Global 3D Bio-Printer Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 3D Bio-Printer Value Chain Analysis
- 9.1.1 3D Bio-Printer Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 3D Bio-Printer Production Mode & Process
- 9.2 3D Bio-Printer Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 3D Bio-Printer Distributors
- 9.2.3 3D Bio-Printer Customers
10 Global 3D Bio-Printer Analyzing Market Dynamics
- 10.1 3D Bio-Printer Industry Trends
- 10.2 3D Bio-Printer Industry Drivers
- 10.3 3D Bio-Printer Industry Opportunities and Challenges
- 10.4 3D Bio-Printer Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst